A World-First in Neonatal Care: Japan Approves Prolacta Bioscience’s 100% Human Milk-Based Fortifiers as a Prescription Drug For Vulnerable Infants.
Skip to main content
Resources & Evidence
Contact us
North America
Europe
Australia
Middle East
Menu
Search
Close Search
Healthcare Professionals
Toggle sub navigation
Clinical
Clinical overview
EHMD Clinical Benefits
Clinical evidence
Clinical education
Financial
Cost-benefit analysis
Parents
Toggle sub navigation
Parent overview
What to expect in the NICU
Your baby's nutrition needs
How to advocate for your baby
Parent stories
Resources for parents
Donors
Toggle sub navigation
Donors overview
Become a donor
Donor stories
Quality & Innovation
Toggle sub navigation
Quality & innovation overview
Human milk safety
Products
Toggle sub navigation
Products overview
Preterm nutrition products
Term nutrition products
About Us
Toggle sub navigation
Get to Know Us
Company overview
Giving back
Leadership
Investors
Careers
Connect With Us
News
Media
Conferences
Contact us
Conferences
Home
>
Conferences
